Skip to main content
Fig. 3 | Molecular Medicine

Fig. 3

From: Administration of zoledronic acid alleviates osteoporosis in HIV patients by suppressing osteoclastogenesis via regulating RANKL expression

Fig. 3

The expression of miR-302, miR-101 and miR-145 in the serum of HIV patients receiving tenofovir treatment was increased by ZOL treatment. a ZOL treatment enhanced the expression of miR-302 in the serum of HIV patients receiving tenofovir treatment. b ZOL treatment enhanced the expression of miR-101 in the serum of HIV patients receiving tenofovir treatment. c ZOL treatment enhanced the expression of miR-145 in the serum of HIV patients receiving tenofovir treatment

Back to article page

Molecular Medicine

ISSN: 1528-3658